Small Molecule Decoy of Amyloid-β Aggregation Blocks Activation of Microglia-Like Cells

Overview

Journal J Alzheimers Dis

Publisher Sage Publications

Specialties Geriatrics
Neurology

Date 2024 Sep 6

PMID 39240634

Authors

Sho Oasa

Gefei Chen

Marianne Schultzberg

Lars Terenius

Affiliations

Soon will be listed here.

Abstract

Background: Aggregated forms of the amyloid-β (Aβ) peptides which form protofibrils and fibrils in the brain are signatures of Alzheimer's disease (AD). Aggregates are also recognized by microglia, which in early phases may be protective and in later phases contribute to the pathology. We have identified several small molecules, decoys which interfere with Aβ oligomerization and induce other aggregation trajectories leading to aggregated macrostructures which are non-toxic.

Objective: This study investigates whether the small-molecule decoys affect microglial activation in terms of cytokine secretion and phagocytosis of Aβ peptide.

Methods: The effects of the decoys (NSC 69318, NSC 100873, NSC 16224) were analyzed in a model of human THP-1 monocytes differentiated to microglia-like cells. The cells were activated by Aβ40 and Aβ42 peptides, respectively, and after treatment with each decoy the secreted levels of pro-inflammatory cytokines and the Aβ phagocytosis were analyzed.

Results: NSC16224, which generates a double-stranded aggregate of thin protofibrils, was found to block Aβ40- and Aβ42-induced increase in microglial secretion of pro-inflammatory cytokines. NSC 69318, selective for neurotoxicity of Aβ42, and NSC 100873 did not significantly reduce the microglial activation in terms of cytokine secretion. The uptake of Aβ42 was not affected by anyone of the decoys.

Conclusions: Our findings open the possibility that the molecular decoys of Aβ aggregation may block microglial activation by Aβ40 and Aβ42 in addition to blocking neurotoxicity as shown previously.

References

Mann D, Iwatsubo T, Fukumoto H, Ihara Y, Odaka A, Suzuki N . Microglial cells and amyloid beta protein (A beta) deposition; association with A beta 40-containing plaques. Acta Neuropathol. 1995; 90(5):472-7. DOI: 10.1007/BF00294808. View

Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland T . A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease. Cell. 2017; 169(7):1276-1290.e17. DOI: 10.1016/j.cell.2017.05.018. View

Yates S, Burgess L, Kocsis-Angle J, Antal J, Dority M, Embury P . Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. J Neurochem. 2000; 74(3):1017-25. DOI: 10.1046/j.1471-4159.2000.0741017.x. View

Serhan C, Savill J . Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005; 6(12):1191-7. DOI: 10.1038/ni1276. View

Sarlus H, Heneka M . Microglia in Alzheimer's disease. J Clin Invest. 2017; 127(9):3240-3249. PMC: 5669553. DOI: 10.1172/JCI90606. View

Rangaraju S, Dammer E, Raza S, Rathakrishnan P, Xiao H, Gao T . Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease. Mol Neurodegener. 2018; 13(1):24. PMC: 5963076. DOI: 10.1186/s13024-018-0254-8. View

Serhan C, Levy B . Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest. 2018; 128(7):2657-2669. PMC: 6025982. DOI: 10.1172/JCI97943. View

Del Bo R, Angeretti N, Lucca E, De Simoni M, Forloni G . Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci Lett. 1995; 188(1):70-4. DOI: 10.1016/0304-3940(95)11384-9. View

Chong Y, Sung J, Shin S, Chung J, Suh Y . Effects of the beta-amyloid and carboxyl-terminal fragment of Alzheimer's amyloid precursor protein on the production of the tumor necrosis factor-alpha and matrix metalloproteinase-9 by human monocytic THP-1. J Biol Chem. 2001; 276(26):23511-7. DOI: 10.1074/jbc.M009466200. View

10.

Harper J, Lansbury Jr P . Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem. 1997; 66:385-407. DOI: 10.1146/annurev.biochem.66.1.385. View

11.

Cadiz M, Gibson K, Todd K, Nascari D, Massa N, Lilley M . Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations. J Exp Med. 2024; 221(2). PMC: 10791560. DOI: 10.1084/jem.20231363. View

12.

Pires L, Rocha D, Ambrosio L, Pego A . The role of the surface on microglia function: implications for central nervous system tissue engineering. J R Soc Interface. 2014; 12(103). PMC: 4305425. DOI: 10.1098/rsif.2014.1224. View

13.

Zhong X, Kumar R, Wang Y, Biverstal H, Ingeborg Jegerschold C, Koeck P . Amyloid Fibril Formation of Arctic Amyloid-β 1-42 Peptide is Efficiently Inhibited by the BRICHOS Domain. ACS Chem Biol. 2022; 17(8):2201-2211. PMC: 9396614. DOI: 10.1021/acschembio.2c00344. View

14.

Bruggink K, Muller M, Kuiperij H, Verbeek M . Methods for analysis of amyloid-β aggregates. J Alzheimers Dis. 2011; 28(4):735-58. DOI: 10.3233/JAD-2011-111421. View

15.

Zhu X, Schrader J, Irizarry B, Smith S, Van Nostrand W . Impact of Aβ40 and Aβ42 Fibrils on the Transcriptome of Primary Astrocytes and Microglia. Biomedicines. 2022; 10(11). PMC: 9688026. DOI: 10.3390/biomedicines10112982. View

16.

Wang Y, Leppert A, Tan S, van der Gaag B, Li N, Schultzberg M . Maresin 1 attenuates pro-inflammatory activation induced by β-amyloid and stimulates its uptake. J Cell Mol Med. 2020; 25(1):434-447. PMC: 7810927. DOI: 10.1111/jcmm.16098. View

17.

Mohd Yasin Z, Mohd Idrus F, Hoe C, Yvonne-Tee G . Macrophage polarization in THP-1 cell line and primary monocytes: A systematic review. Differentiation. 2022; 128:67-82. DOI: 10.1016/j.diff.2022.10.001. View

18.

Lukiw W, Cui J, Marcheselli V, Bodker M, Botkjaer A, Gotlinger K . A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest. 2005; 115(10):2774-83. PMC: 1199531. DOI: 10.1172/JCI25420. View

19.

Do K, Hjorth E, Wang Y, Jun B, Kautzmann M, Ohshima M . Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer's Disease. Cell Mol Neurobiol. 2022; 43(2):797-811. PMC: 9957874. DOI: 10.1007/s10571-022-01216-5. View

20.

Araujo D, Cotman C . Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res. 1992; 569(1):141-5. DOI: 10.1016/0006-8993(92)90380-r. View